Tissue-specific expression of mast cell granule serine proteinases and their role in inflammation in the lung and gut

Immunology

Volumn 105, Issue 4, 2002, Pages 375-390

  Miller, Hugh R P ^a,b   Pemberton, Alan D ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN I; BRADYKININ; CHYMASE; GLYCOSAMINOGLYCAN; GRANZYME B; HEPARIN; IMMUNOGLOBULIN E; INTERLEUKIN 3; MAST CELL PROTEINASE 10; MAST CELL PROTEINASE 2; MAST CELL PROTEINASE 3; MAST CELL PROTEINASE 4; MAST CELL PROTEINASE 5; MAST CELL PROTEINASE 6; MAST CELL PROTEINASE 8; MAST CELL PROTEINASE 9; MATRIX METALLOPROTEINASE; PROTEINASE; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE INHIBITOR; PROTEOGLYCAN; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; SERINE PROTEINASE; SULFOTRANSFERASE; TETRAMER; TRANSFORMING GROWTH FACTOR BETA1; TRYPTASE; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AIRWAY; AMINO ACID SEQUENCE; BLOOD VESSEL PERMEABILITY; CELL ACTIVATION; ENTERITIS; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME RELEASE; ENZYME SPECIFICITY; HUMAN; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; MAST CELL; NONHUMAN; PNEUMONIA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVIEW;

ANIMALS; BACTERIAL INFECTIONS; CAPILLARY PERMEABILITY; CHYMASES; HUMANS; INTESTINAL MUCOSA; LUNG; MAST CELLS; NEMATODE INFECTIONS; SERINE ENDOPEPTIDASES; SPECIES SPECIFICITY; TISSUE DISTRIBUTION; TRYPTASES;

EID: 0036228009     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2002.01375.x     Document Type: Review

References (212)

1. The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000
2. Mucosal mast cells and the allergic response against nematode parasites
3. Mucosal mast cells in the rat and in man
4. Intestinal mast cell polymorphism: New research directions and clinical implications
5. Human mast cell heterogeneity
6. Phenotypic expression of mast cell granule proteinases. Distribution of mast cell proteinases I and II in the rat digestive system
7. Strain-specific and tissue-specific expression of mouse mast cell secretory granule proteases
8. Independent influence of strain difference and mi transcription factor on the expression of mouse mast cell chymases
9. cDNA sequence of two sheep mast cell tryptases and the differential expression of tryptase and sheep mast cell proteinase-1 in lung, dermis and gastrointestinal tract
10. Functional correlations between mucosal mast cell activity and immunity to Trichinella spiralis in high and low responder mice
11. Interaction of murine intestinal mast cell proteinase with inhibitors (serpins) in blood; analysis by SDS-PAGE and Western blotting
12. Mast cells
13. Tryptase, a mediator of human mast cells
14. Delayed expulsion of the nematode Trichinella spiralis in mice lacking the mucosal mast cell-specific granule chymase, mouse mast cell protease-1
15. Colonic mucin release in response to immobilization stress is mast cell dependent
16. Response of mucosal mast cells to intestinal ischemia-reperfusion injury in the rat
17. Intraepithelial migration of nasal mucosal mast cells in hay fever
18. Granule chymases and the characterization of mast cell phenotype and function in rat and mouse
19. Histochemical and ultrastructural modification of mucosal mast cell granules in parasitized mice lacking the beta-chymase, mouse mast cell protease-1
20. Cloning and characterization of complementary DNA for human tryptase
21. Characterization of genes encoding known and novel human mast cell tryptases on chromosome 16p13.3
22. Human mast cell tryptase: Multiple cDNAs and genes reveal a multigene serine protease family
23. Cloning and characterization of a second complementary DNA for human tryptase
24. Characterization of human gamma-tryptases, novel members of the chromosome 16p mast cell tryptase and prostasin gene families
25. Identification of a new member of the tryptase family of mouse and human mast cell proteases which possesses a novel COOH-terminal hydrophobic extension
26. Structure, chromosomal assignment, and deduced amino acid sequence of a human gene for mast cell chymase
27. Cloning of the gene and cDNA for human heart chymase
28. Molecular cloning of human cathepsin G. structural similarity to mast cell and cytotoxic T lymphocyte proteinases
29. Amino acid sequence of a mouse mucosal mast cell protease
30. Cloning of the cDNA and gene for mouse mast cell protease 4. Demonstration of its late transcription in mast cell subclasses and analysis of its homology to subclass-specific neutral proteases of the mouse and rat
31. Cloning and structural analysis of MMCP-1, MMCP-4 and MMCP-5, three mouse mast cell-specific serine proteases
32. Molecular cloning of the mouse mast cell protease-5 gene. A novel secretory granule protease expressed early in the differentiation of serosal mast cells
33. Cloning of the cDNA and gene of mouse mast cell protease-6. Transcription by progenitor mast cells and mast cells of the connective tissue subclass
34. Isolation, characterization, and transcription of the gene encoding mouse mast cell protease 7
35. Amino acid sequence of rat mast cell protease I (chymase)
36. Covalent structure of a group-specific protease from rat small intestine. Appendix: Crystallographic data for a group specific protease from rat intestine
37. Cloning of the mast cell protease, RMCP II. Evidence for cell-specific expression and a multi-gene family
38. cDNA sequencing and expression of rat mast cell tryptase
39. Tryptase from rat skin: Purification and properties
40. Secretory granule proteases in rat mast cells. Cloning of 10 different serine proteases and a carboxypeptidase A from various rat mast cell populations
41. Molecular cloning of dog mast cell tryptase and a related protease: Structural evidence of a unique mode of serine protease activation
42. Purification and characterization of dog mastocytoma chymase: Identification of an octapeptide conserved in chymotryptic leukocyte proteinases
43. Dog mast cell chymase. Molecular cloning and characterization
44. Sheep mast-cell proteinases-1 and -3: cDNA cloning, primary structure and molecular modelling of the enzymes and further studies on substrate specificity
45. cDNA cloning and primary structure of tryptase from bovine mast cells, and evidence for the expression of bovine pancreatic trypsin inhibitor mRNA in the same cells
46. Duodenase, a new serine protease of unusual specificity from bovine duodenal mucosa. Primary structure of the enzyme
47. Mast cell proteases: A historical perspective
48. Neutral proteases of the mast cell
49. A major serine protease in rat skeletal muscle: Evidence for its mast cell origin
50. Immunofluorescent localization of a serine protease in rat small intestine
51. Angiotensin II-forming activity in a reconstructed ancestral chymase
52. Human skin chymotryptic proteinase. Isolation and relation to cathepsin G and rat mast cell proteinase I
53. Serine proteinases of mast cell and leukocyte granules. A league of their own
54. Tryptase from human pulmonary mast cells. Purification and characterization
55. Tryptase and chymase in dog mast cells
56. Localization of rat tryptase to a subset of the connective tissue type of mast cell
57. Tryptase 4, a new member of the chromosome 17 family of mouse serine proteases
58. Identification of a cathepsin G-like proteinase in the MCTC type of human mast cell
59. Mast cell and neutrophil expression of dog mast cell protease-3. A novel tryptase-related serine protease
60. Mast cell subsets in the rat distinguished immunohistochemically by their content of serine proteinases
61. A kinetic analysis of the expression of mast cell protease mRNA in the intestines of Nippostrongylus brasiliensis-infected rats
62. Rat mucosal mast cells: The cultured bone marrow-derived mast cell is biochemically and functionally analogous to its counterpart in vivo
63. Characterization and mast cell origin of a chymotrypsin-like proteinase isolated from intestines of mice infected with Trichinella spiralis
64. Mast cell heterogeneity in the gastrointestinal tract: Variable expression of mouse mast cell protease-1 (mMCP-1) in intraepithelial mucosal mast cells in nematode-infected and normal BALB/c mice
65. Biochemical and immunological characterization of multiple glycoforms of mouse mast cell protease 1: Comparison with an isolated murine serosal mast cell protease (MMCP-4)
66. Mast cells that reside at different locations in the jejunum of mice infected with Trichinella spiralis exhibit sequential changes in their granule ultrastructure and chymase phenotype
67. Quantitative analysis of mucosal mast cell protease in the intestines of Nippostrongylus-infected rats
68. The influence of challenge dose, duration of immunity, or steroid treatment on mucosal mast cells and on the distribution of sheep mast cell proteinase in Haemonchus-infected sheep
69. Distribution of intestinal mast cell proteinase in blood and tissues of normal and Trichinella-infected mice
70. Reversible expression of tryptases and chymases in the jejunal mast cells of mice infected with Trichinella spiralis
71. Expression of mast-cell-specific proteases in tissues of mice studied by in situ hybridization
72. Cloning of the cDNA encoding a novel rat mast-cell proteinase, rMCP-3, and its expression in comparison with other rat mast-cell proteinases
73. Two types of human mast cells that have distinct neutral protease compositions
74. Quantitative assessment of mast cells and expression of IgE protein and mRNA for IgE and interleukin 4 in the gastrointestinal tract of healthy dogs and dogs with inflammatory bowel disease
75. The immunohistochemical demonstration of chymase and tryptase in human intestinal mast cells
76. Number, fixation properties, dye-binding and protease expression of duodenal mast cells: Comparisons between healthy subjects and patients with gastritis or Crohn's disease
77. Mast cell tryptase levels in normal canine tissues
78. Granule proteinases define mast cell heterogeneity in the serosa and the gastrointestinal mucosa of the mouse
79. Role of mast cells in anaphylaxis. Evidence for the importance of mast cells in the cardiopulmonary alterations and death induced by anti-IgE in mice
80. The number and distribution of mast cells in monkey lungs
81. Mast cells in the ovine lower respiratory tract: Heterogeneity, morphology and density
82. Mast cells in the bovine lower respiratory tract: Morphology, density and distribution
83. Detection of tryptase in bovine mast cells. Comparison of enzyme- and immuno-histochemistry
84. Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies
85. Distribution of chymase-containing mast cells in human bronchi
86. Altered expression of mast cell proteases in the rat. Quantitative and immunohistochemical analysis of the distribution of rat mast cell proteases I and II during helminth infection
87. Expression of mast cell proteases in rat lung during helminth infection: Mast cells express both rat mast cell protease II and tryptase in helminth infected lung
88. Local lung responses following local lung challenge with recombinant lungworm antigen in systemically sensitized sheep
89. Identification of oversulphated galactosaminoglycans in intestinal-mucosal mast cells of rats infected with the nematode worm Nippostrongylus brasiliensis
90. Intestinal mucosal mast cells from rats infected with Nippostrongylus brasiliensis contain protease-resistant chondroitin sulfate di-B proteoglycans
91. Heparin is essential for the storage of specific granule proteases in mast cells
92. Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme
93. Packaging of proteases and proteoglycans in the granules of mast cells and other hematopoietic cells. A cluster of histidines on mouse mast cell protease 7 regulates its binding to heparin serglycin proteoglycans
94. Regulation of human mast cell tryptase. Effects of enzyme concentration, ionic strength and the structure and negative charge density of polysaccharides
95. Fate of two mast cell tryptases in V3 mastocytosis and normal BALB/c mice undergoing passive systemic anaphylaxis: Prolonged retention of exocytosed mMCP-6 in connective tissues, and rapid accumulation of enzymatically active mMCP-7 in the blood
96. The presence in blood of both glycosaminoglycan and mucosal mast cell protease following systemic anaphylaxis in the rat
97. Phenotypic expression of proteoglycan in mast cells of the human nasal mucosa
98. Systemic release of mucosal mast-cell protease in primed rats challenged with Nippostrongylus brasiliensis
99. Mucosal mast cells are functionally active during spontaneous expulsion of intestinal nematode infections in rat
100. Systemic release of a mast cell proteinase following nematode infections in sheep
101. Anaphylactic release of mucosal mast cell protease and its relationship to gut permeability in Nippostrongylus-primed rats
102. Pavlovian conditioning of rat mucosal mast cells to secrete rat mast cell protease II
103. Mast cell protease release and mucosal ultrastructure during intestinal anaphylaxis in the rat
104. Release of the mucosal mast cell granule chymase, rat mast cell protease-II, during anaphylaxis is associated with the rapid development of paracellular permeability to macromolecules in rat jejunum
105. The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis
106. Mast cell activation in arthritis: Detection of alpha- and beta-tryptase, histamine and eosinophil cationic protein in synovial fluid
107. Activation of pulmonary mast cells by bronchoalveolar allergen challenge. In vivo release of histamine and tryptase in atopic subjects with and without asthma
108. Elevated histamine and tryptase levels in smokers' bronchoalveolar lavage fluid. Do lung mast cells contribute to smokers' emphysema?
109. Tear and conjunctival changes during the allergen-induced early- and late-phase responses
110. Allergen challenge-induced entry of alpha 2-macroglobulin and tryptase into human nasal and bronchial airways
111. Histamine and tryptase levels in patients with acute allergic reactions: An emergency department-based study
112. Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol
113. Role of mast cells in chronic stress induced colonic epithelial barrier dysfunction in the rat
114. Interactions of human mast cell tryptase with biological protease inhibitors
115. Postmortem serum levels of tryptase and total and specific IgE in fatal asthma
116. Evaluation of human peripheral blood leukocytes for mast cell tryptase
117. Tryptase: A clinical indicator of mast cell-dependent events
118. Development of mucosal mast cells after injection of a single connective tissue-type mast cell in the stomach mucosa of genetically mast cell-deficient W/Wv mice
119. Multiple bidirectional alterations of phenotype and changes in proliferative potential during the in vitro and in vivo passage of clonal mast cell populations derived from mouse peritoneal mast cells
120. Alteration of protease expression phenotype of mouse peritoneal mast cells by changing the microenvironment as demonstrated by in situ hybridization histochemistry
121. Generation of mucosal mast cells is stimulated in vitro by factors derived from T cells of helminth-infected rats
122. Transcriptional regulation of the mucosal mast cell-specific protease gene, MMCP-2, by interleukin 10 and interleukin 3
123. Characterisation of ovine mast cells derived from in vitro culture of haemopoietic tissue
124. Mouse bone marrow-derived mast cells (mBMMC) obtained in vitro from mice that are mast cell-deficient in vivo express the same panel of granule proteases as mBMMC and serosal mast cells from their normal littermates
125. Selective growth of human mast cells induced by Steel factor, IL-6, and prostaglandin E2 from cord blood mononuclear cells
126. Effects of stem cell factor (kit-ligand) and interleukin-3 on the growth and serine proteinase expression of rat bone-marrow-derived or serosal mast cells
127. Interleukin-4 promotes the development of tryptase and chymase double-positive human mast cells accompanied by cell maturation
128. Mast cells expressing chymase but not tryptase can be derived by culturing human progenitors in conditioned medium obtained from a human mastocytosis cell strain with c-kit ligand
129. Selective down-regulation of high-affinity IgE receptor (FcepsilonRI) alpha-chain messenger RNA among transcriptome in cord blood-derived versus adult peripheral blood-derived cultured human mast cells
130. Regulation of chymase production in human mast cell progenitors
131. Effect of recombinant human IL-4 on tryptase, chymase, and Fc epsilon receptor type I expression in recombinant human stem cell factor-dependent fetal liver-derived human mast cells
132. Constitutive expression of mouse mast cell protease-1 in normal BALB/c mice and its up-regulation during intestinal nematode infection
133. TGF-beta 1 mediates co-expression of the integrin subunit alpha E and the chymase mouse mast cell protease-1 during the early differentiation of bone marrow-derived mucosal mast cell homologues
134. A novel function for transforming growth factor-beta 1: Upregulation of the expression and the IgE-independent extracellular release of a mucosal mast cell granule-specific beta-chymase, mouse mast cell protease-1
135. Murine M290 integrin expression modulated by mast cell activation
136. Mucosal T cells and mast cells share common adhesion receptors
137. Healing the epithelium: Solving the problem from two sides
138. Characterization of the integrin alpha v beta 6 as a fibronectin-binding protein
139. The integrin alpha v beta 6 binds and activates latent TGF beta 1: A mechanism for regulating pulmonary inflammation and fibrosis
140. Intraepithelial infiltration by mast cells with both connective tissue-type and mucosal-type characteristics in gut, trachea, and kidneys of IL-9 transgenic mice
141. Activation of paracrine TGF-beta 1 signaling upon stimulation and degranula-tion of rat serosal mast cells: A novel function for chymase
142. Induction of chymase that forms angiotensin II in the monkey atherosclerotic aorta
143. Purification and identification of two serine class proteinases from dog mast biochemically and immunologically similar to human proteinases tryptase and chymase
144. Distinct multisite synergistic interactions determine substrate specificities of human chymase and rat chymase-1 for angiotensin II formation and degradation
145. The structure of the pro-apoptotic protease granzyme B reveals the molecular determinants of its specificity
146. The 1.8 A crystal structure of human cathepsin G in complex with Suc-Val-Pro-PheP-(OPh) 2: A Janus-faced proteinase with two opposite specificities
147. Duodenase, a new serine protease of unusual specificity from bovine duodenal mucosa: Purification and properties
148. Characterization of mouse mast cell protease-8, the first member of a novel subfamily of mouse mast cell serine proteases, distinct from both the classical chymases and tryptases
149. Human beta-tryptase is a ring-like tetramer with active sites facing a central pore
150. Human tryptases alpha and beta/II are functionally distinct due, in part, to a single amino acid difference in one of the surface loops that forms the substrate-binding cleft
151. Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase
152. Inactivation of human high molecular weight kininogen by human mast cell tryptase
153. Identification of human lung mast cell kininogenase as tryptase and relevance of tryptase kininogenase activity
154. Induction of vascular permeability enhancement by human tryptase: Dependence on activation of prekallikrein and direct release of bradykinin from kininogens
155. The fibrinogenolytic activity of purified tryptase from human lung mast cells
156. Pericellular substrates of human mast cell tryptase. 72,000 dalton gelatinase and fibronectin
157. Mitogenic responses mediated through the proteinase-activated receptor- 2 are induced by expressed forms of mast cell alpha- or beta-tryptases
158. Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation
159. Secretory leukocyte protease inhibitor prevents allergen-induced pulmonary responses in animal models of asthma
160. Bovine tryptase: Purification and characterization
161. Lactoferrin, a potent tryptase inhibitor, abolishes late-phase airway responses in allergic sheep
162. Neutrophil myeloperoxidase is a potent and selective inhibitor of mast cell tryptase
163. Cleavage of type I procollagen by human mast cell chymase initiates collagen fibril formation and generates a unique carboxyl-terminal propeptide
164. Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond by mast cell chymase
165. Dog mastocytoma cells secrete a 92-kD gelatinase activated extracellularly by mast cell chymase
166. Highly efficient inhibition of human chymase by alpha(2)-macroglobulin
167. Reaction of human skin chymotrypsin-like proteinase chymase with plasma proteinase inhibitors
168. Inhibition of human mast cell chymase by secretory leukocyte proteinase inhibitor: Enhancement of the interaction by heparin
169. Activation of precursors for matrix metalloproteinases 1 (interstitial collagenase) and 3 (stromelysin) by rat mast-cell proteinases I and II
170. Differential inhibition of rat mast cell proteinase I and II by members of the alpha-1-proteinase inhibitor family of serine proteinase inhibitors
171. Differential inhibition of mast cell chymases by secretory leukocyte protease inhibitor
172. Sheep mast cell proteinase-1, a serine proteinase with both tryptase- and chymase-like properties, is inhibited by plasma proteinase inhibitors and is mitogenic for bovine pulmonary artery fibroblasts
173. Alpha 2-macroglobulin, a multifunctional binding protein with targeting characteristics
174. The serpin superfamily of proteinase inhibitors: Structure, function, and regulation
175. Diverse effects of pH on the inhibition of human chymase by serpins
176. Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor
177. Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing
178. Regulation of rat mast cell protease 1 activity. Protease inhibition is prevented by heparin proteoglycan
179. Chymase bound to heparin is resistant to its natural inhibitors and capable of proteolyzing high density lipoproteins in aortic intimal fluid
180. Human lung tryptase. Purification and characterization
181. Regulation of tryptase from human lung mast cells by heparin. Stabilization of the active tetramer
182. Human skin tryptase: Kinetic characterization of its spontaneous inactivation
183. A novel mechanism for bradykinin production at inflammatory sites. Diverse effects of a mixture of neutrophil elastase and mast cell tryptase versus tissue and plasma kallikreins on native and oxidized kininogens
184. The tryptase, mouse mast cell protease 7, exhibits anticoagulant activity in vivo and in vitro due to its ability to degrade fibrinogen in the presence of the diverse array of protease inhibitors in plasma
185. Human mast cell tryptase fibrinogenolysis: Kinetics, anticoagulation mechanism, and cell adhesion disruption
186. Human mast cell tryptase: A stimulus of microvascular leakage and mast cell activation
187. Role of tryptase in immediate cutaneous responses in allergic sheep
188. The induction of a prolonged increase in microvascular permeability by human mast cell chymase
189. Focal dermal-epidermal separation and fibronectin cleavage in basement membrane by human mast cell tryptase
190. Catabolism of intact type VI collagen microfibrils: Susceptibility to degradation by serine proteinases
191. Mast cell proteinases activate precursor forms of collagenase and stromelysin, but not of gelatinases A and B
192. Proteinase-activated receptors: A growing family of heptahelical receptors for thrombin, trypsin and tryptase
193. Selected contribution: Tryptase-induced PAR-2-mediated Ca (2+) signaling in human airway smooth muscle cells
194. Tryptase and agonists of PAR-2 induce the proliferation of human airway smooth muscle cells
195. Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2
196. Reaction of mast cell proteases tryptase and chymase with protease activated receptors (PARs) on keratinocytes and fibroblasts
197. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases
198. Conditional and targeted overexpression of vascular chymase causes hypertension in transgenic mice
199. Chymase mediates mast cell-induced angiogenesis in hamster sponge granulomas
200. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis
201. Inhaled tryptase causes bronchoconstriction in sheep via histamine release
202. Tryptase inhibitors block allergen-induced airway and inflammatory responses in allergic sheep
203. Induction of a selective and persistent extravasation of neutrophils into the peritoneal cavity by tryptase mouse mast cell protease 6
204. Potent induction of a neutrophil and eosinophil-rich infiltrate in vivo by human mast cell tryptase: Selective enhancement of eosinophil recruitment by histamine
205. Mast cell tryptase is a mitogen for epithelial cells. Stimulation of IL-8 production and inter-cellular adhesion molecule-1 expression
206. The role of mast cell tryptase in regulating endothelial cell proliferation, cytokine release, and adhesion molecule expression: Tryptase induces expression of mRNA for IL-1 beta and IL-8 and stimulates the selective release of IL-8 from human umbilical vein endothelial cells
207. Human mast cell chymase induces the accumulation of neutrophils, eosinophils and other inflammatory cells in vivo
208. The rat mucosal mast cell chymase, RMCP-II, alters epithelial cell monolayer permeability in association with altered distribution of the tight junction proteins ZO-1 and occludin
209. Globule leukocytes in the lumen of the small intestine and the resistance status of sheep infected with parasitic nematodes
210. Immunization of sheep against parasitic nematodes leads to elevated levels of globule leukocytes in the small intestine lumen
211. The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells
212. Human mast cell tryptase beta I: Evaluation of its substrate specificity and demonstration of its importance in bacterial infections of the lung